G

    Grace Therapeutics, Inc. (GRCE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.13
    +0.01 (+0.47%)

    Market Cap: $44.60M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(19/30)
    Avg Surprise
    -34.16%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.21
    Range$-0.21 - $-0.21
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.20+1.4%
    60d ago$-0.20+1.4%
    30d ago$-0.18+11.5%
    7d ago$-0.18+11.5%
    Current$-0.21
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Dec 31, 2026
    EPS Consensus$-0.21
    Range$-0.21 - $-0.21
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.20+1.4%
    60d ago$-0.20+1.4%
    30d ago$-0.18+11.5%
    7d ago$-0.18+11.5%
    Current$-0.21
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$-0.16---
    Dec 26EST
    		-$-0.21---
    Sep 26EST
    		-$-0.21---
    Jun 26
    		$-0.91$-0.18-405.56%Miss-213.8%
    Mar 26
    		$-0.08N/A+60.00%Beat-260.0%
    Dec 25
    		$-0.19N/A+51.28%Beat+62.9%
    Sep 25
    		$-0.08N/A+76.47%Beat+80.9%
    Jun 25
    		$-0.29$-0.31+6.45%Beat+12.1%
    Mar 25
    		$0.05N/A+112.55%Beat+114.0%
    Dec 24
    		$-0.51$-0.46-11.67%Miss-82.8%
    Sep 24
    		$-0.42$-0.50+16.79%Beat-34.9%
    Jun 24
    		$-0.33$-0.36+8.33%Beat+31.2%
    Mar 24
    		$-0.36$-0.47+24.13%Beat+45.1%
    Dec 23
    		$-0.28$-0.31+9.68%Beat+61.1%
    Sep 23
    		$-0.31$-0.35+11.43%Beat-181.8%
    Jun 23
    		$-0.48$-0.37-29.73%Miss-380.0%
    Mar 23
    		$-0.65$-0.14-364.29%Miss-109.7%
    Dec 22
    		$-0.72$-1.01+28.71%Beat-4.3%
    Sep 22
    		$-0.11N/AN/ABeat-266.7%
    Jun 22
    		$-0.10N/AN/ABeat-25.0%
    Mar 22
    		$-0.31N/A+69.00%Beat-29.2%
    Dec 21
    		$-0.69$-0.62-11.29%Miss+62.3%
    Sep 21
    		$-0.03N/AN/ABeat+99.2%
    Jun 21
    		$-0.08N/AN/ABeat+97.5%
    Mar 21
    		$-0.24$-0.04-500.00%Miss-209.1%
    Dec 20
    		$-1.83$-2.50+26.80%Beat+78.8%
    Sep 20
    		$-3.77$-3.17-18.93%Miss+76.9%
    Jun 20
    		$-3.17$-3.89+18.51%Beat+56.0%
    Mar 20
    		$0.22$-0.09+344.44%Beat+1064.9%
    Dec 19
    		$-8.64$-4.59-88.24%Miss-157.1%
    Sep 19
    		$-16.32$-5.28-209.09%Miss+45.2%
    Jun 19
    		$-7.20$-8.09+11.00%Beat+34.8%
    Mar 19
    		$-0.02N/A+79.27%Beat+99.8%
    Dec 18
    		$-3.36$-4.80+30.00%Beat+82.5%
    Sep 18
    		$-29.76$-6.72-342.86%Miss-154.1%
    Jun 18
    		$-11.04$-12.96+14.81%Beat-63.7%
    Mar 18
    		$-12.14N/AN/ABeat-49.9%
    Dec 17
    		$-19.20$-13.44-42.86%Miss-138.6%
    Sep 17
    		$-11.71N/AN/ABeat-
    Jun 17
    		$-6.74N/AN/ABeat-
    Dec 16
    		$-8.10N/AN/ABeat-
    Sep 16
    		$-8.05N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.69EV/EBITDA19.61x
    Price/FCF-3.57xFCF Yield-28.00%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-36.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio11.47xQuick Ratio11.47x
    Trading Statistics
    Beta0.43Avg Volume147.00K
    52-Week High$5.1852-Week Low$1.79

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.16
    SMA 20$2.15
    SMA 50$2.26
    SMA 200$3.09
    EMA 10$2.15
    EMA 20$2.17
    EMA 50$2.27
    EMA 200$2.81

    MACD

    Line: -0.03Signal: -0.04Hist: 0.01

    ADX

    ADX: 18.9+DI: 12.2-DI: 25.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down8.0
    PSAR$2.33

    Bollinger Bands

    Upper Band$2.22
    Lower Band$2.07
    %B Position659%(Upper)
    Band Width0.39

    RSI (14-Day)

    Neutral
    44.2

    Momentum Oscillators

    Stoch %K50.7
    Stoch %D56.5
    Williams %R-52.2
    ROC (10d)-1.4%
    Momentum-0.03
    CCI (20d)-73.8
    MFI (14d)49.8

    Volatility Measures

    ATR (14d)$0.10(4.7%)
    StdDev (20d)0.04
    Hist Vol34.3%(Moderate)

    Volume Flow

    VWAP$2.11
    OBV-10.0M
    AD Line-9.5M
    CMF (20d)0.063

    Volume Metrics

    Avg Vol (20d)149.5K
    Vol Ratio0.8x
    VWMA (20d)$2.14

    Pivot Points

    R3$2.19
    R2$2.17
    R1$2.15
    Pivot Point$2.13
    S1$2.11
    S2$2.09
    S3$2.07

    Advanced Oscillators

    TSI-10.51
    Ultimate Osc53.3
    KST-47.65

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total RevenueN/A$0$0$0$0$8,000$0$0$0$0$0$0
    Cost of RevenueN/A$2,000$4,116$2,000$2,000$2,000$2,000$2,000$1,000$1,000$1,000$2,000
    Gross ProfitN/A$-2,000$-4,116$-2,000$-2,000$-2,000$-2,000$-2,000$-1,000$-1,000$-1,000$-2,000
    Operating Expenses$15.79M$3.01M$3.36M$3.53M$3.09M$4.53M$5.33M$4.83M$6.79M$4.43M$4.03M$2.83M
    R&D$697,000$420,000$633,924$792,206$955,000$2.33M$3.16M$2.98M$3.70M$2.29M$1.91M$622,945
    SG&A$1.69M$308,589$2.72M$2.73M$2.13M$2.20M$2.17M$1.85M$3.08M$2.01M$2.08M$2.21M
    Operating Income$-15,790,000$-3,010,000$-3,360,346$-3,527,272$-3,090,000$-4,532,942$-5,326,685$-4,831,000$-6,787,547$-4,427,923$-4,033,474$-2,833,049
    Interest Income$0$138,000$170,000$172,000$205,000$167,000$138,000$172,000$235,000$249,000$316,000$212,000
    Interest Expense$0$0$0$0$272,000$0$0$0$0$1.07M$0$2.20M
    Income Before Tax$-15,790,000$-2,878,000$-3,176,480$-1,308,256$-3,362,000$-544,010$0$-4,284,000$-4,569,251$-5,502,675$-3,444,955$-5,036,381
    Income Tax Expense$0$-1,700,000$0$0$0$-1,449,743$-870,044$-852,000$-990,164$-1,206,381$-275,702$-603,986
    Net Income$-15,790,000$-1,178,000$-3,176,480$-1,308,256$-3,362,000$905,733$-5,975,263$-3,432,000$-3,579,087$-4,296,293$-3,169,253$-4,432,394
    EBITDA$-15,788,000$-3,008,000$-3,356,229$-3,525,877$-3,088,000$-4,530,093$-5,323,809$-4,829,000$-6,786,180$-4,380,428$-4,032,149N/A
    EBIT$-15,790,000$-3,010,000$-3,360,345$-3,527,271$-3,090,000$-4,532,941$-5,326,685$-4,831,000$-6,787,547$-4,427,923$-4,033,474N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRCE

    News

    No news available

    Company news will appear here when available

    Frequently Asked Questions About GRCE

    Does GRCE pay dividends?
    Grace Therapeutics, Inc. (GRCE) does not currently pay a regular dividend.
    What is GRCE's market cap?
    Grace Therapeutics, Inc. (GRCE) has a market capitalization of $44.60M with a current stock price of $2.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In